Microline Surgical Appoints Sharad Joshi as CEO

  Microline Surgical Appoints Sharad Joshi as CEO

Business Wire

BEVERLY, Mass. -- April 02, 2013

Dr. Jean-Luc Boulnois, Chairman of the Board of Directors of Microline
Surgical, Inc., announced today that, on his recommendation, the Board has
appointed Sharad H. Joshi as Microline’s new President and Chief Executive
Officer (CEO), effective April 1^st, 2013.

As part of this new leadership strategy, Microline’s Board has also appointed
Dr. Boulnois as Executive Chairman of the company, a leading manufacturer of
reposable instruments for minimally invasive surgery. Dr. Boulnois has served
as Microline’s Chairman and CEO for the last eight years.

Mr. Joshi has been a member of the Microline executive team since 2007, having
most recently served as President and Chief Operating Officer (COO). He brings
over 25 years of medical device industry experience, including leadership
positions in Business Development, Marketing, Sales, Operations and R&D. Prior
to joining Microline, Joshi was Founder, President and CEO of Blue Torch
Medical Technologies. Previously, he held positions with Boston Scientific and
Alliant Medical Technologies.

According to Dr. Boulnois, the Microline Board has elected to bring in new
leadership to reengineer the company’s operational functions and continue to
better serve its partners, physician customers and their patients, while
furthering its successful expansion into global markets.

“The last eight years have been extraordinary for Microline, with the company
growing at an incredible 17 percent year-on-year average rate,” said Dr.
Boulnois. “Mr. Joshi has played an integral part in Microline’s tremendous
growth as we’ve successfully extended our reach into the surgical marketplace
both organically and through the introduction of the MiFusion energy product

“This is a time of tremendous promise and change in the healthcare industry as
surgeons expand minimally invasive surgical techniques into new procedural
areas in an effort to reduce complications and improve outcomes for their
patients,” said Joshi. “Microline is uniquely positioned for growth in the
field of laparoscopy with our strong management team, global resources,
aggressive business development strategy and exceptional products.”

In executing this new leadership strategy, Joshi, together with his recently
expanded Senior Management team, will work closely with Microline’s Board of
Directors. As Executive Chairman, Dr. Boulnois will concentrate on long term
strategic objectives, while creating and developing partnerships that
complement Microline’s core business and enhance shareholder value.

About Microline Surgical

Headquartered in Beverly, Massachusetts, Microline Surgical, Inc. is a leading
U.S. medical device manufacturer of high quality reposable surgical
laparoscopic instruments. Founded in 1987, Microline is a wholly owned
subsidiary of HOYA Corporation (7741:TSE) in Tokyo, Japan, a $4.5 billion
company with approximately half of its revenues from medical business
including endoscopy and eye care. Microline’s integrated modular laparoscopic
instrumentation system consists of a selection of reusable handpieces that
utilize a broad assortment of disposable tips. This concept allows for
surgical efficiency and cost effectiveness to be preserved at all times. The
company’s patented product portfolio comprises cutting, dissecting, grasping,
cauterizing and ligating instruments used in all laparoscopic surgical
procedures as well as tissue welding and vessel sealing technology used
worldwide for open and endoscopic cardiac, gynecology, general surgery,
otolaryngology, and urology procedures. Microline Surgical products are sold
in over 60 countries, with the vast majority of its manufacturing being done
in the United States. For more information, visit www.microlinesurgical.com.


Microline Surgical
Kristina Cabel, 978-867-1761
Director of Marketing
Press spacebar to pause and continue. Press esc to stop.